Oroxylum Indicum ameliorates chemotherapy induced cognitive impairment.

While chemotherapy is the most effective therapeutic approach for treating a variety of cancer patients, commonly used chemotherapeutic agents, often induce several adverse effects. Escalating evidence indicates that chemotherapeutics, particularly doxorubicin (DOX) and cyclophosphamide (CPS), induc...

Full description

Bibliographic Details
Main Authors: Satyanarayana R Pondugula, Mohammed Majrashi, Mohammed Almaghrabi, Sindhu Ramesh, Kodye L Abbott, Manoj Govindarajulu, Kristina Gill, Eddie Fahoury, Natasha Narayanan, Darshini Desai, Jun Ren, Rishi Nadar, Trey McElroy, Timothy Moore, Muhammed Majeed, Nagabhushanam Kalyanam, Muralikrishnan Dhanasekaran
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0252522
id doaj-52b5bde371c24b3bac72c7874af7e8d3
record_format Article
spelling doaj-52b5bde371c24b3bac72c7874af7e8d32021-06-19T04:34:45ZengPublic Library of Science (PLoS)PLoS ONE1932-62032021-01-01166e025252210.1371/journal.pone.0252522Oroxylum Indicum ameliorates chemotherapy induced cognitive impairment.Satyanarayana R PondugulaMohammed MajrashiMohammed AlmaghrabiSindhu RameshKodye L AbbottManoj GovindarajuluKristina GillEddie FahouryNatasha NarayananDarshini DesaiJun RenRishi NadarTrey McElroyTimothy MooreMuhammed MajeedNagabhushanam KalyanamMuralikrishnan DhanasekaranWhile chemotherapy is the most effective therapeutic approach for treating a variety of cancer patients, commonly used chemotherapeutic agents, often induce several adverse effects. Escalating evidence indicates that chemotherapeutics, particularly doxorubicin (DOX) and cyclophosphamide (CPS), induce cognitive impairment associated with central nervous system toxicity. This study was performed to determine neuroprotective effects of Oroxylum indicum extract (OIE) in regard to preventing chemotherapy induced cognitive impairment (CICI) occurring after 4 cycles of DOX (2mg/kg) and CPS (50mg/kg) combination chemotherapy in male C57BL/6J mice. OIE significantly prevented the chemotherapy impaired short-term cognitive performance, exploratory behavior associated with cognitive performance, cognitive performance, and spatial learning and memory in the Y-maze, Open-Field, Novel Object Recognition, and Morris Water Maze tests, respectively. These data suggest that OIE protects from the CICI. OIE decreased the reactive oxygen species and lipid peroxide generated by the chemotherapy treatment in the brain, while also blocking the chemotherapy-induced glutathione depletion. These results establish that OIE exhibits potent antioxidant activity in chemotherapy treated mice. Notably, OIE significantly increased the Complex-I and Complex-IV activities in the brain, indicating that OIE enhances mitochondrial function in the brain. In silico analysis of the major active chemical constituents (Oroxylin A, Baicalein and Chrysin) of OIE indicated that OIE has a favorable absorption, distribution, metabolism and excretion (ADME) profile. Taken together, our results are consistent with the conclusion that OIE prevents CICI by counteracting oxidative stress and perhaps by improving mitochondrial function.https://doi.org/10.1371/journal.pone.0252522
collection DOAJ
language English
format Article
sources DOAJ
author Satyanarayana R Pondugula
Mohammed Majrashi
Mohammed Almaghrabi
Sindhu Ramesh
Kodye L Abbott
Manoj Govindarajulu
Kristina Gill
Eddie Fahoury
Natasha Narayanan
Darshini Desai
Jun Ren
Rishi Nadar
Trey McElroy
Timothy Moore
Muhammed Majeed
Nagabhushanam Kalyanam
Muralikrishnan Dhanasekaran
spellingShingle Satyanarayana R Pondugula
Mohammed Majrashi
Mohammed Almaghrabi
Sindhu Ramesh
Kodye L Abbott
Manoj Govindarajulu
Kristina Gill
Eddie Fahoury
Natasha Narayanan
Darshini Desai
Jun Ren
Rishi Nadar
Trey McElroy
Timothy Moore
Muhammed Majeed
Nagabhushanam Kalyanam
Muralikrishnan Dhanasekaran
Oroxylum Indicum ameliorates chemotherapy induced cognitive impairment.
PLoS ONE
author_facet Satyanarayana R Pondugula
Mohammed Majrashi
Mohammed Almaghrabi
Sindhu Ramesh
Kodye L Abbott
Manoj Govindarajulu
Kristina Gill
Eddie Fahoury
Natasha Narayanan
Darshini Desai
Jun Ren
Rishi Nadar
Trey McElroy
Timothy Moore
Muhammed Majeed
Nagabhushanam Kalyanam
Muralikrishnan Dhanasekaran
author_sort Satyanarayana R Pondugula
title Oroxylum Indicum ameliorates chemotherapy induced cognitive impairment.
title_short Oroxylum Indicum ameliorates chemotherapy induced cognitive impairment.
title_full Oroxylum Indicum ameliorates chemotherapy induced cognitive impairment.
title_fullStr Oroxylum Indicum ameliorates chemotherapy induced cognitive impairment.
title_full_unstemmed Oroxylum Indicum ameliorates chemotherapy induced cognitive impairment.
title_sort oroxylum indicum ameliorates chemotherapy induced cognitive impairment.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2021-01-01
description While chemotherapy is the most effective therapeutic approach for treating a variety of cancer patients, commonly used chemotherapeutic agents, often induce several adverse effects. Escalating evidence indicates that chemotherapeutics, particularly doxorubicin (DOX) and cyclophosphamide (CPS), induce cognitive impairment associated with central nervous system toxicity. This study was performed to determine neuroprotective effects of Oroxylum indicum extract (OIE) in regard to preventing chemotherapy induced cognitive impairment (CICI) occurring after 4 cycles of DOX (2mg/kg) and CPS (50mg/kg) combination chemotherapy in male C57BL/6J mice. OIE significantly prevented the chemotherapy impaired short-term cognitive performance, exploratory behavior associated with cognitive performance, cognitive performance, and spatial learning and memory in the Y-maze, Open-Field, Novel Object Recognition, and Morris Water Maze tests, respectively. These data suggest that OIE protects from the CICI. OIE decreased the reactive oxygen species and lipid peroxide generated by the chemotherapy treatment in the brain, while also blocking the chemotherapy-induced glutathione depletion. These results establish that OIE exhibits potent antioxidant activity in chemotherapy treated mice. Notably, OIE significantly increased the Complex-I and Complex-IV activities in the brain, indicating that OIE enhances mitochondrial function in the brain. In silico analysis of the major active chemical constituents (Oroxylin A, Baicalein and Chrysin) of OIE indicated that OIE has a favorable absorption, distribution, metabolism and excretion (ADME) profile. Taken together, our results are consistent with the conclusion that OIE prevents CICI by counteracting oxidative stress and perhaps by improving mitochondrial function.
url https://doi.org/10.1371/journal.pone.0252522
work_keys_str_mv AT satyanarayanarpondugula oroxylumindicumameliorateschemotherapyinducedcognitiveimpairment
AT mohammedmajrashi oroxylumindicumameliorateschemotherapyinducedcognitiveimpairment
AT mohammedalmaghrabi oroxylumindicumameliorateschemotherapyinducedcognitiveimpairment
AT sindhuramesh oroxylumindicumameliorateschemotherapyinducedcognitiveimpairment
AT kodyelabbott oroxylumindicumameliorateschemotherapyinducedcognitiveimpairment
AT manojgovindarajulu oroxylumindicumameliorateschemotherapyinducedcognitiveimpairment
AT kristinagill oroxylumindicumameliorateschemotherapyinducedcognitiveimpairment
AT eddiefahoury oroxylumindicumameliorateschemotherapyinducedcognitiveimpairment
AT natashanarayanan oroxylumindicumameliorateschemotherapyinducedcognitiveimpairment
AT darshinidesai oroxylumindicumameliorateschemotherapyinducedcognitiveimpairment
AT junren oroxylumindicumameliorateschemotherapyinducedcognitiveimpairment
AT rishinadar oroxylumindicumameliorateschemotherapyinducedcognitiveimpairment
AT treymcelroy oroxylumindicumameliorateschemotherapyinducedcognitiveimpairment
AT timothymoore oroxylumindicumameliorateschemotherapyinducedcognitiveimpairment
AT muhammedmajeed oroxylumindicumameliorateschemotherapyinducedcognitiveimpairment
AT nagabhushanamkalyanam oroxylumindicumameliorateschemotherapyinducedcognitiveimpairment
AT muralikrishnandhanasekaran oroxylumindicumameliorateschemotherapyinducedcognitiveimpairment
_version_ 1721372109602553856